Table of Contents
ISRN Pharmacology
Volume 2011 (2011), Article ID 347134, 4 pages
http://dx.doi.org/10.5402/2011/347134
Review Article

Dendritic Cell-Based Graft Tolerance

Laboratory of Environnemental Immuno-Microbiology and Cancerogenesis (IMEC Unit), Department of Biology, Faculty of Sciences of Bizerte, Zarzouna 7021, Tunisia

Received 12 January 2011; Accepted 7 February 2011

Academic Editor: Y. L. Hsu

Copyright © 2011 Mnasria Kaouther and Oueslati Ridha. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Reis E Sousa, “Activation of dendritic cells: translating innate into adaptive immunity,” Current Opinion in Immunology, vol. 16, no. 1, pp. 21–25, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. R. M. Steinman, D. Hawiger, and M. C. Nussenzweig, “Tolerogenic dendritic cells,” Annual Review of Immunology, vol. 21, pp. 685–711, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. J. Banchereau, F. Briere, C. Caux et al., “Immunobiology of dendritic cells,” Annual Review of Immunology, vol. 18, pp. 767–811, 2000. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. J. Banchereau and R. M. Steinman, “Dendritic cells and the control of immunity,” Nature, vol. 392, no. 6673, pp. 245–252, 1998. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. R. M. Steinman, B. Gutchinov, M. D. Witmer, and M. C. Nussenzweig, “Dendritic cells are the principal stimulators of the primary mixed leukocyte reaction in mice,” Journal of Experimental Medicine, vol. 157, no. 2, pp. 613–627, 1983. View at Google Scholar · View at Scopus
  6. F. Granucci, C. Vizzardelli, N. Pavelka et al., “Inducible IL-2 production by dendritic cells revealed by global gene expression analysis,” Nature Immunology, vol. 2, no. 9, pp. 882–888, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. S. E. Macatonia, N. A. Hosken, M. Litton et al., “Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells,” Journal of Immunology, vol. 154, no. 10, pp. 5071–5079, 1995. View at Google Scholar · View at Scopus
  8. M. Moser and K. M. Murphy, “Dendritic cell regulation of T1-T2 development,” Nature Immunology, vol. 1, no. 3, pp. 199–205, 2000. View at Google Scholar · View at Scopus
  9. R. M. Steinman and M. C. Nussenzweig, “Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 1, pp. 351–358, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. N. C. Fernandez, A. Lozier, C. Flament et al., “Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo,” Nature Medicine, vol. 5, no. 4, pp. 405–411, 1999. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. F. Granucci, I. Zanoni, N. Pavelka et al., “A contribution of mouse dendritic cell-derived IL-2 for NK cell activation,” Journal of Experimental Medicine, vol. 200, no. 3, pp. 287–295, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. S. Feau, V. Facchinetti, F. Granucci et al., “Dendritic cell-derived IL-2 production is regulated by IL-15 in humans and in mice,” Blood, vol. 105, no. 2, pp. 697–702, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. V. Kronin, D. Vremec, and K. Shortman, “Does the IL-2 receptor α chain induced on dendritic cells have a biological function?” International Immunology, vol. 10, no. 2, pp. 237–240, 1998. View at Publisher · View at Google Scholar · View at Scopus
  14. B. Bielekova, M. Catalfamo, S. Reichert-Scrivner et al., “Regulatory CD56 natural killer cells mediate immunomodulatory effects of IL-2Rα-targeted therapy (daclizumab) in multiple sclerosis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 15, pp. 5941–5946, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. B. Bielekova, N. Richert, T. Howard et al., “Humanized anti-CD25 (daclizumab) inhibits disease activity in multiple sclerosis patients failing to respond to interferon β,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 23, pp. 8705–8708, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. F. Vincenti, R. Kirkman, S. Light et al., “Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation,” New England Journal of Medicine, vol. 338, no. 3, pp. 161–165, 1998. View at Publisher · View at Google Scholar · View at PubMed